October 01, 2014 6:32 AM ET

Pharmaceuticals

Company Overview of Critical Biologics Corporation

Company Overview

Critical Biologics Corp., a development stage biotechnology company, develops and commercializes diagnostics and therapeutics that predict and regulate inflammatory responses to life-threatening diseases. The company focuses on a theranostic approach to treat critical care patients with low plasma gelsolin (pGSN) levels at high risk of life-threatening complications. Its products include SolinDx, an ELISA assay kit used for the measurement of pGSN in human plasma samples; ActinDx, an ELISA assay kit used for the quantitative measurement of the amount of circulating actin in serum; and Solinex, an investigational drug. The company has a strategic partnership wit QSV Biologics, Ltd. to manufac...

One Mifflin Place

Suite 400

Cambridge, MA 02138

United States

Founded in 2004

Phone:

908-439-9768

Fax:

908-439-9768

Key Executives for Critical Biologics Corporation

Co-Founder and Chairman
Age: 71
Founding Scientist and Director
Founding Scientist
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Mycosol, Inc. United States
Pharmalogix Inc. United States
The Daily Wellness Company United States
Xttrium Laboratories, Inc. United States
Health & Beyond Nutra Company Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Critical Biologics Corporation, please visit www.criticalbiologics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.